 | • レポートコード：MRC2-11QY04319 • 出版社/出版日：QYResearch / 2020年11月20日 ※2024年版があります。お問い合わせください。 • レポート形態：英文、PDF、98ページ • 納品方法：Eメール（納期：2~3日） • 産業分類：ヘルスケア |
| Single User | ￥577,200 (USD3,900) | ▷ お問い合わせ |
| Multi User | ￥865,800 (USD5,850) | ▷ お問い合わせ |
| Enterprise License | ￥1,154,400 (USD7,800) | ▷ お問い合わせ |
• お支払方法：銀行振込（納品後、ご請求書送付）
レポート概要
| 当調査資料は多嚢胞性卵巣症候群治療のグローバル市場について調査・分析したレポートです。種類別（経口避妊薬、インスリン増感剤、抗うつ剤、オルニチン、デカルボキシラーゼ阻害剤、アロマターゼ阻害剤およびSERM、利尿剤）市場規模、用途別（病院薬局、ドラッグストア、Eコマース、不妊治療クリニック）市場規模、地域別（北米、米国、カナダ、ヨーロッパ、ドイツ、フランス、イギリス、イタリア、ロシア、アジア、日本、中国、韓国、インド、オーストラリア、台湾、中南米、メキシコ、ブラジル、アルゼンチン、中東・アフリカ、トルコ、サウジアラビア、UAE等）市場規模データ、主な企業情報と企業別市場シェア等が収録されています。 ・調査範囲 ・エグゼクティブサマリー ・企業別多嚢胞性卵巣症候群治療の競争状況、市場シェア ・世界の多嚢胞性卵巣症候群治療市場：種類別市場規模 2015年-2020年（経口避妊薬、インスリン増感剤、抗うつ剤、オルニチン、デカルボキシラーゼ阻害剤、アロマターゼ阻害剤およびSERM、利尿剤） ・世界の多嚢胞性卵巣症候群治療市場：種類別市場規模予測 2021年-2026年（経口避妊薬、インスリン増感剤、抗うつ剤、オルニチン、デカルボキシラーゼ阻害剤、アロマターゼ阻害剤およびSERM、利尿剤） ・世界の多嚢胞性卵巣症候群治療市場：用途別市場規模 2015年-2020年（病院薬局、ドラッグストア、Eコマース、不妊治療クリニック） ・世界の多嚢胞性卵巣症候群治療市場：用途別市場規模予測 2021年-2026年（病院薬局、ドラッグストア、Eコマース、不妊治療クリニック） ・北米の多嚢胞性卵巣症候群治療市場分析：米国、カナダ ・ヨーロッパの多嚢胞性卵巣症候群治療市場分析：ドイツ、フランス、イギリス、イタリア、ロシア等 ・アジアの多嚢胞性卵巣症候群治療市場分析：日本、中国、韓国、インド、オーストラリア、台湾等 ・中南米の多嚢胞性卵巣症候群治療市場分析：メキシコ、ブラジル、アルゼンチン等 ・中東・アフリカの多嚢胞性卵巣症候群治療市場分析：トルコ、サウジアラビア、UAE等 ・企業情報（企業概要、製品概要、販売量、企業動向） - 掲載企業（変更可能性あり）：Sanofi、Novartis、Teva Pharmaceutical Industries、Merck、AstraZeneca ・地域別市場規模予測（2021年-2026年）：北米市場、ヨーロッパ市場、アジア市場、中南米市場、中東・アフリカ市場 ・市場機会、課題、リスク、環境分析 ・バリューチェーン、販売チャネル分析 ・調査の結論 |
Polycystic ovary syndrome is a set of symptoms due to elevated androgens in females.
Signs and symptoms of polycystic ovary syndrome nclude irregular or no menstrual periods, heavy periods, excess body and facial hair, acne, pelvic pain, difficulty getting pregnant and patches of thick, darker, velvety skin.
Market Analysis and Insights: Global Polycystic Ovarian Syndrome Treatment Market
The global Polycystic Ovarian Syndrome Treatment market size is projected to reach US$ 3201.8 million by 2026, from US$ 3106.6 million in 2020, at a CAGR of 2.8%% during 2021-2026.
Global Polycystic Ovarian Syndrome Treatment Scope and Market Size
Polycystic Ovarian Syndrome Treatment market is segmented by Type, and by Application. Players, stakeholders, and other participants in the global Polycystic Ovarian Syndrome Treatment market will be able to gain the upper hand as they use the report as a powerful resource. The segmental analysis focuses on revenue and forecast by Type and by Application in terms of revenue and forecast for the period 2015-2026.
The key players covered in this study
Sanofi
Novartis
Teva Pharmaceutical Industries
Merck
AstraZeneca
…
Market segment by Type, the product can be split into
Oral Contraceptives
Insulin Sensitizing Agents
Anti-Depressants
Ornithine
Decarboxylase Inhibitors
Aromatase Inhibitors and SERMs
Diuretics
Market segment by Application, split into
Hospital Pharmacies
Drug Stores
E-Commerce
Fertility Clinics
Market segment by Regions/Countries, this report covers
North America
Europe
China
Japan
Southeast Asia
India
1 Report Overview
1.1 Study Scope
1.2 Key Market Segments
1.3 Players Covered: Ranking by Polycystic Ovarian Syndrome Treatment Revenue
1.4 Market by Type
1.4.1 Global Polycystic Ovarian Syndrome Treatment Market Size Growth Rate by Type: 2020 VS 2026
1.4.2 Oral Contraceptives
1.4.3 Insulin Sensitizing Agents
1.4.4 Anti-Depressants
1.4.5 Ornithine
1.4.6 Decarboxylase Inhibitors
1.4.7 Aromatase Inhibitors and SERMs
1.4.8 Diuretics
1.5 Market by Application
1.5.1 Global Polycystic Ovarian Syndrome Treatment Market Share by Application: 2020 VS 2026
1.5.2 Hospital Pharmacies
1.5.3 Drug Stores
1.5.4 E-Commerce
1.5.5 Fertility Clinics
1.6 Study Objectives
1.7 Years Considered
2 Global Growth Trends
2.1 Global Polycystic Ovarian Syndrome Treatment Market Perspective (2015-2026)
2.2 Global Polycystic Ovarian Syndrome Treatment Growth Trends by Regions
2.2.1 Polycystic Ovarian Syndrome Treatment Market Size by Regions: 2015 VS 2020 VS 2026
2.2.2 Polycystic Ovarian Syndrome Treatment Historic Market Share by Regions (2015-2020)
2.2.3 Polycystic Ovarian Syndrome Treatment Forecasted Market Size by Regions (2021-2026)
2.3 Industry Trends and Growth Strategy
2.3.1 Market Top Trends
2.3.2 Market Drivers
2.3.3 Market Challenges
2.3.4 Porter’s Five Forces Analysis
2.3.5 Polycystic Ovarian Syndrome Treatment Market Growth Strategy
2.3.6 Primary Interviews with Key Polycystic Ovarian Syndrome Treatment Players (Opinion Leaders)
3 Competition Landscape by Key Players
3.1 Global Top Polycystic Ovarian Syndrome Treatment Players by Market Size
3.1.1 Global Top Polycystic Ovarian Syndrome Treatment Players by Revenue (2015-2020)
3.1.2 Global Polycystic Ovarian Syndrome Treatment Revenue Market Share by Players (2015-2020)
3.1.3 Global Polycystic Ovarian Syndrome Treatment Market Share by Company Type (Tier 1, Tier 2 and Tier 3)
3.2 Global Polycystic Ovarian Syndrome Treatment Market Concentration Ratio
3.2.1 Global Polycystic Ovarian Syndrome Treatment Market Concentration Ratio (CR5 and HHI)
3.2.2 Global Top 10 and Top 5 Companies by Polycystic Ovarian Syndrome Treatment Revenue in 2019
3.3 Polycystic Ovarian Syndrome Treatment Key Players Head office and Area Served
3.4 Key Players Polycystic Ovarian Syndrome Treatment Product Solution and Service
3.5 Date of Enter into Polycystic Ovarian Syndrome Treatment Market
3.6 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type (2015-2026)
4.1 Global Polycystic Ovarian Syndrome Treatment Historic Market Size by Type (2015-2020)
4.2 Global Polycystic Ovarian Syndrome Treatment Forecasted Market Size by Type (2021-2026)
5 Market Size by Application (2015-2026)
5.1 Global Polycystic Ovarian Syndrome Treatment Market Size by Application (2015-2020)
5.2 Global Polycystic Ovarian Syndrome Treatment Forecasted Market Size by Application (2021-2026)
6 North America
6.1 North America Polycystic Ovarian Syndrome Treatment Market Size (2015-2020)
6.2 Polycystic Ovarian Syndrome Treatment Key Players in North America (2019-2020)
6.3 North America Polycystic Ovarian Syndrome Treatment Market Size by Type (2015-2020)
6.4 North America Polycystic Ovarian Syndrome Treatment Market Size by Application (2015-2020)
7 Europe
7.1 Europe Polycystic Ovarian Syndrome Treatment Market Size (2015-2020)
7.2 Polycystic Ovarian Syndrome Treatment Key Players in Europe (2019-2020)
7.3 Europe Polycystic Ovarian Syndrome Treatment Market Size by Type (2015-2020)
7.4 Europe Polycystic Ovarian Syndrome Treatment Market Size by Application (2015-2020)
8 China
8.1 China Polycystic Ovarian Syndrome Treatment Market Size (2015-2020)
8.2 Polycystic Ovarian Syndrome Treatment Key Players in China (2019-2020)
8.3 China Polycystic Ovarian Syndrome Treatment Market Size by Type (2015-2020)
8.4 China Polycystic Ovarian Syndrome Treatment Market Size by Application (2015-2020)
9 Japan
9.1 Japan Polycystic Ovarian Syndrome Treatment Market Size (2015-2020)
9.2 Polycystic Ovarian Syndrome Treatment Key Players in Japan (2019-2020)
9.3 Japan Polycystic Ovarian Syndrome Treatment Market Size by Type (2015-2020)
9.4 Japan Polycystic Ovarian Syndrome Treatment Market Size by Application (2015-2020)
10 Southeast Asia
10.1 Southeast Asia Polycystic Ovarian Syndrome Treatment Market Size (2015-2020)
10.2 Polycystic Ovarian Syndrome Treatment Key Players in Southeast Asia (2019-2020)
10.3 Southeast Asia Polycystic Ovarian Syndrome Treatment Market Size by Type (2015-2020)
10.4 Southeast Asia Polycystic Ovarian Syndrome Treatment Market Size by Application (2015-2020)
11 India
11.1 India Polycystic Ovarian Syndrome Treatment Market Size (2015-2020)
11.2 Polycystic Ovarian Syndrome Treatment Key Players in India (2019-2020)
11.3 India Polycystic Ovarian Syndrome Treatment Market Size by Type (2015-2020)
11.4 India Polycystic Ovarian Syndrome Treatment Market Size by Application (2015-2020)
12 Central & South America
12.1 Central & South America Polycystic Ovarian Syndrome Treatment Market Size (2015-2020)
12.2 Polycystic Ovarian Syndrome Treatment Key Players in Central & South America (2019-2020)
12.3 Central & South America Polycystic Ovarian Syndrome Treatment Market Size by Type (2015-2020)
12.4 Central & South America Polycystic Ovarian Syndrome Treatment Market Size by Application (2015-2020)
13 Key Players Profiles
13.1 Sanofi
13.1.1 Sanofi Company Details
13.1.2 Sanofi Business Overview
13.1.3 Sanofi Polycystic Ovarian Syndrome Treatment Introduction
13.1.4 Sanofi Revenue in Polycystic Ovarian Syndrome Treatment Business (2015-2020))
13.1.5 Sanofi Recent Development
13.2 Novartis
13.2.1 Novartis Company Details
13.2.2 Novartis Business Overview
13.2.3 Novartis Polycystic Ovarian Syndrome Treatment Introduction
13.2.4 Novartis Revenue in Polycystic Ovarian Syndrome Treatment Business (2015-2020)
13.2.5 Novartis Recent Development
13.3 Teva Pharmaceutical Industries
13.3.1 Teva Pharmaceutical Industries Company Details
13.3.2 Teva Pharmaceutical Industries Business Overview
13.3.3 Teva Pharmaceutical Industries Polycystic Ovarian Syndrome Treatment Introduction
13.3.4 Teva Pharmaceutical Industries Revenue in Polycystic Ovarian Syndrome Treatment Business (2015-2020)
13.3.5 Teva Pharmaceutical Industries Recent Development
13.4 Merck
13.4.1 Merck Company Details
13.4.2 Merck Business Overview
13.4.3 Merck Polycystic Ovarian Syndrome Treatment Introduction
13.4.4 Merck Revenue in Polycystic Ovarian Syndrome Treatment Business (2015-2020)
13.4.5 Merck Recent Development
13.5 AstraZeneca
13.5.1 AstraZeneca Company Details
13.5.2 AstraZeneca Business Overview
13.5.3 AstraZeneca Polycystic Ovarian Syndrome Treatment Introduction
13.5.4 AstraZeneca Revenue in Polycystic Ovarian Syndrome Treatment Business (2015-2020)
13.5.5 AstraZeneca Recent Development
14 Analyst’s Viewpoints/Conclusions
15 Appendix
15.1 Research Methodology
15.1.1 Methodology/Research Approach
15.1.2 Data Source
15.2 Disclaimer
15.3 Author Details
Table 1. Polycystic Ovarian Syndrome Treatment Key Market Segments
Table 2. Key Players Covered: Ranking by Polycystic Ovarian Syndrome Treatment Revenue
Table 3. Ranking of Global Top Polycystic Ovarian Syndrome Treatment Manufacturers by Revenue (US$ Million) in 2019
Table 4. Global Polycystic Ovarian Syndrome Treatment Market Size Growth Rate by Type (US$ Million): 2020 VS 2026
Table 5. Key Players of Oral Contraceptives
Table 6. Key Players of Insulin Sensitizing Agents
Table 7. Key Players of Anti-Depressants
Table 8. Key Players of Ornithine
Table 9. Key Players of Decarboxylase Inhibitors
Table 10. Key Players of Aromatase Inhibitors and SERMs
Table 11. Key Players of Diuretics
Table 12. Global Polycystic Ovarian Syndrome Treatment Market Size Growth by Application (US$ Million): 2020 VS 2026
Table 13. Global Polycystic Ovarian Syndrome Treatment Market Size by Regions (US$ Million): 2020 VS 2026
Table 14. Global Polycystic Ovarian Syndrome Treatment Market Size by Regions (2015-2020) (US$ Million)
Table 15. Global Polycystic Ovarian Syndrome Treatment Market Share by Regions (2015-2020)
Table 16. Global Polycystic Ovarian Syndrome Treatment Forecasted Market Size by Regions (2021-2026) (US$ Million)
Table 17. Global Polycystic Ovarian Syndrome Treatment Market Share by Regions (2021-2026)
Table 18. Market Top Trends
Table 19. Key Drivers: Impact Analysis
Table 20. Key Challenges
Table 21. Polycystic Ovarian Syndrome Treatment Market Growth Strategy
Table 22. Main Points Interviewed from Key Polycystic Ovarian Syndrome Treatment Players
Table 23. Global Polycystic Ovarian Syndrome Treatment Revenue by Players (2015-2020) (Million US$)
Table 24. Global Polycystic Ovarian Syndrome Treatment Market Share by Players (2015-2020)
Table 25. Global Top Polycystic Ovarian Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polycystic Ovarian Syndrome Treatment as of 2019)
Table 26. Global Polycystic Ovarian Syndrome Treatment by Players Market Concentration Ratio (CR5 and HHI)
Table 27. Key Players Headquarters and Area Served
Table 28. Key Players Polycystic Ovarian Syndrome Treatment Product Solution and Service
Table 29. Date of Enter into Polycystic Ovarian Syndrome Treatment Market
Table 30. Mergers & Acquisitions, Expansion Plans
Table 31. Global Polycystic Ovarian Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 32. Global Polycystic Ovarian Syndrome Treatment Market Size Share by Type (2015-2020)
Table 33. Global Polycystic Ovarian Syndrome Treatment Revenue Market Share by Type (2021-2026)
Table 34. Global Polycystic Ovarian Syndrome Treatment Market Size Share by Application (2015-2020)
Table 35. Global Polycystic Ovarian Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 36. Global Polycystic Ovarian Syndrome Treatment Market Size Share by Application (2021-2026)
Table 37. North America Key Players Polycystic Ovarian Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 38. North America Key Players Polycystic Ovarian Syndrome Treatment Market Share (2019-2020)
Table 39. North America Polycystic Ovarian Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 40. North America Polycystic Ovarian Syndrome Treatment Market Share by Type (2015-2020)
Table 41. North America Polycystic Ovarian Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 42. North America Polycystic Ovarian Syndrome Treatment Market Share by Application (2015-2020)
Table 43. Europe Key Players Polycystic Ovarian Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 44. Europe Key Players Polycystic Ovarian Syndrome Treatment Market Share (2019-2020)
Table 45. Europe Polycystic Ovarian Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 46. Europe Polycystic Ovarian Syndrome Treatment Market Share by Type (2015-2020)
Table 47. Europe Polycystic Ovarian Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 48. Europe Polycystic Ovarian Syndrome Treatment Market Share by Application (2015-2020)
Table 49. China Key Players Polycystic Ovarian Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 50. China Key Players Polycystic Ovarian Syndrome Treatment Market Share (2019-2020)
Table 51. China Polycystic Ovarian Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 52. China Polycystic Ovarian Syndrome Treatment Market Share by Type (2015-2020)
Table 53. China Polycystic Ovarian Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 54. China Polycystic Ovarian Syndrome Treatment Market Share by Application (2015-2020)
Table 55. Japan Key Players Polycystic Ovarian Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 56. Japan Key Players Polycystic Ovarian Syndrome Treatment Market Share (2019-2020)
Table 57. Japan Polycystic Ovarian Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 58. Japan Polycystic Ovarian Syndrome Treatment Market Share by Type (2015-2020)
Table 59. Japan Polycystic Ovarian Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 60. Japan Polycystic Ovarian Syndrome Treatment Market Share by Application (2015-2020)
Table 61. Southeast Asia Key Players Polycystic Ovarian Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 62. Southeast Asia Key Players Polycystic Ovarian Syndrome Treatment Market Share (2019-2020)
Table 63. Southeast Asia Polycystic Ovarian Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 64. Southeast Asia Polycystic Ovarian Syndrome Treatment Market Share by Type (2015-2020)
Table 65. Southeast Asia Polycystic Ovarian Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 66. Southeast Asia Polycystic Ovarian Syndrome Treatment Market Share by Application (2015-2020)
Table 67. India Key Players Polycystic Ovarian Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 68. India Key Players Polycystic Ovarian Syndrome Treatment Market Share (2019-2020)
Table 69. India Polycystic Ovarian Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 70. India Polycystic Ovarian Syndrome Treatment Market Share by Type (2015-2020)
Table 71. India Polycystic Ovarian Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 72. India Polycystic Ovarian Syndrome Treatment Market Share by Application (2015-2020)
Table 73. Central & South America Key Players Polycystic Ovarian Syndrome Treatment Revenue (2019-2020) (Million US$)
Table 74. Central & South America Key Players Polycystic Ovarian Syndrome Treatment Market Share (2019-2020)
Table 75. Central & South America Polycystic Ovarian Syndrome Treatment Market Size by Type (2015-2020) (Million US$)
Table 76. Central & South America Polycystic Ovarian Syndrome Treatment Market Share by Type (2015-2020)
Table 77. Central & South America Polycystic Ovarian Syndrome Treatment Market Size by Application (2015-2020) (Million US$)
Table 78. Central & South America Polycystic Ovarian Syndrome Treatment Market Share by Application (2015-2020)
Table 79. Sanofi Company Details
Table 80. Sanofi Business Overview
Table 81. Sanofi Product
Table 82. Sanofi Revenue in Polycystic Ovarian Syndrome Treatment Business (2015-2020) (Million US$)
Table 83. Sanofi Recent Development
Table 84. Novartis Company Details
Table 85. Novartis Business Overview
Table 86. Novartis Product
Table 87. Novartis Revenue in Polycystic Ovarian Syndrome Treatment Business (2015-2020) (Million US$)
Table 88. Novartis Recent Development
Table 89. Teva Pharmaceutical Industries Company Details
Table 90. Teva Pharmaceutical Industries Business Overview
Table 91. Teva Pharmaceutical Industries Product
Table 92. Teva Pharmaceutical Industries Revenue in Polycystic Ovarian Syndrome Treatment Business (2015-2020) (Million US$)
Table 93. Teva Pharmaceutical Industries Recent Development
Table 94. Merck Company Details
Table 95. Merck Business Overview
Table 96. Merck Product
Table 97. Merck Revenue in Polycystic Ovarian Syndrome Treatment Business (2015-2020) (Million US$)
Table 98. Merck Recent Development
Table 99. AstraZeneca Company Details
Table 100. AstraZeneca Business Overview
Table 101. AstraZeneca Product
Table 102. AstraZeneca Revenue in Polycystic Ovarian Syndrome Treatment Business (2015-2020) (Million US$)
Table 103. AstraZeneca Recent Development
Table 104. Research Programs/Design for This Report
Table 105. Key Data Information from Secondary Sources
Table 106. Key Data Information from Primary Sources
List of Figures
Figure 1. Global Polycystic Ovarian Syndrome Treatment Market Share by Type: 2020 VS 2026
Figure 2. Oral Contraceptives Features
Figure 3. Insulin Sensitizing Agents Features
Figure 4. Anti-Depressants Features
Figure 5. Ornithine Features
Figure 6. Decarboxylase Inhibitors Features
Figure 7. Aromatase Inhibitors and SERMs Features
Figure 8. Diuretics Features
Figure 9. Global Polycystic Ovarian Syndrome Treatment Market Share by Application: 2020 VS 2026
Figure 10. Hospital Pharmacies Case Studies
Figure 11. Drug Stores Case Studies
Figure 12. E-Commerce Case Studies
Figure 13. Fertility Clinics Case Studies
Figure 14. Polycystic Ovarian Syndrome Treatment Report Years Considered
Figure 15. Global Polycystic Ovarian Syndrome Treatment Market Size YoY Growth 2015-2026 (US$ Million)
Figure 16. Global Polycystic Ovarian Syndrome Treatment Market Share by Regions: 2020 VS 2026
Figure 17. Global Polycystic Ovarian Syndrome Treatment Market Share by Regions (2021-2026)
Figure 18. Porter's Five Forces Analysis
Figure 19. Global Polycystic Ovarian Syndrome Treatment Market Share by Players in 2019
Figure 20. Global Top Polycystic Ovarian Syndrome Treatment Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Polycystic Ovarian Syndrome Treatment as of 2019
Figure 21. The Top 10 and 5 Players Market Share by Polycystic Ovarian Syndrome Treatment Revenue in 2019
Figure 22. North America Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 23. Europe Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 24. China Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 25. Japan Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 26. Southeast Asia Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 27. India Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 28. Central & South America Polycystic Ovarian Syndrome Treatment Market Size YoY Growth (2015-2020) (Million US$)
Figure 29. Bottom-up and Top-down Approaches for This Report
Figure 30. Data Triangulation
Figure 31. Key Executives Interviewed
多嚢胞性卵巣症候群（PCOS）治療薬の世界市場（～2026年） Market Analysis and Insights: Global Polycystic Ovary Syndrome (PCOS) Drugs Market The global Polycystic Ovary Syndrome (PCOS) Drugs market size is projected to reach US$ XX million by 2026, from US$ XX million in 2020, at a CAGR of XX%% during 2021-2026. Global Polycystic Ovary Syndrome (PCOS) Drug…- バーター症候群治療の世界市場（～2026年） Bartter syndrome is a rare genetic disorder that causes specific defects in kidney function. The global market for Bartter syndrome treatment is expected to witness a moderate growth rate over the forecast period. Market Analysis and Insights: Global Bartter Syndrome Treatment Market The global Bart…
- クッシング症候群治療の世界市場（～2026年） Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. In terms of…
- クッシング症候群・先端巨大症治療の世界市場（～2026年） Cushing's syndrome involves symptoms such as high blood pressure, abdominal obesity, round red face, a fatty lump between the shoulders, weak muscles and bones, acne, fragile skin and others. Most Cushing's syndrome cases are caused by pituitary adenoma, and multiple endocrine neoplasia. Acromegaly …
- ドラベ症候群治療の世界市場（～2026年） Dravet syndrome is a rare, severe form of intractable epilepsy. It occurs due to a mutation in the SCN1A gene, which is required for the proper function of brain cells. Although there is no cure for Dravet syndrome, most treatments aim to reduce seizures. First line anti-seizure medications include …